nChroma Bio

Venture Round
nchromabio.com Biotech & Healthcare Boston, United States 51-100
Total Funding $75M
Latest Round $75M Venture Round
Last Announced Dec 12, 2024
Investors 10 Backers
Decision Makers 5 Verified

About nChroma Bio

Develops genetic medicines using targeted in vivo delivery.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Venture Round
Global Headquarters Boston, United States
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website nchromabio.com
Domain Registered Date Dec 2, 2024

Social & Network Presence

X / Twitter Profile @nchromabio (111 followers) Created on Dec 2024
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $75,000,000 · Venture Round

    fundraisingfox.com

  2. Milestone

    X account created (@nchromabio)

    111 followers

  3. Milestone

    Website domain registered

    nchromabio.com

Investors & Backers

10
Cormorant Asset Management
DCVC Bio
GV
Janus Henderson Investors
Mubadala Capital Ventures
Omega Funds
Sixth Street
Sofinnova Partners
Wellington Management
Wilson Sonsini Goodrich & Rosati

Funding History

1 Round
Venture Round · Dec 12, 2024

Founders & Leadership

4

Jeffrey Walsh

CEO

Work email & phone locked Unlock →

Jenny Marlowe

CDO

Work email & phone locked Unlock →

Melissa Bonner

CSO

Work email & phone locked Unlock →

Noah Goodman

CBO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts